Term
Clusters (Staph)
1. Coagulase positive (1)
2. Gram ? |
|
Definition
|
|
Term
Clusters (Staph)
1. Coagulase negative (3)
2. Gram? |
|
Definition
1. S. epidermidis
2. S. saprophytcus
3. S. hominis
*Gram Positive |
|
|
Term
Pairs or Chains (Streptococcus)
1. Beta-hemolytic (2 with groups)
2. Alpha-hemolytic
3. Gram? |
|
Definition
1. S. pyogenese; S. agalactiae (Groups C, F, and G)
2. Viridans strep; S. pneumoniae
3. Positive |
|
|
Term
Pairs or Chains (Enterococcus)
1. Gram?
2. Spp (2) |
|
Definition
1. Positive
2. E. facaelis; E. faecium |
|
|
Term
Gram Negative Cocci
1. spp (2) |
|
Definition
1. Neisseria meningitidis
2. N. gonhorrea |
|
|
Term
Gram Negative Bacilli
1. Lactose fermenters (3)
2. Which ones are enterobacteriaceae |
|
Definition
1. E. coli; Kelbsiella sp; Enterobacter sp
2. ALL are enterobacteriaceae |
|
|
Term
Gram Negative Bacilli
1. Non-lactose fermenters (9)
2. Which ones are enterobacteriaceae (Bold) |
|
Definition
1. Pseudomonas aeruginosa
2. Moraxella sp
3. Serratia sp
4. Morganella sp
5. Salmonella sp
6. Shigella sp.
7. Proteus sp.
8. Stenotrophomonas
9. Acinetobacter sp |
|
|
Term
Gram positive anaerobes (2) |
|
Definition
1. Peptostreptococcus
2. Clostridium sp |
|
|
Term
Gram Negative Anaerobe (1) |
|
Definition
|
|
Term
|
Definition
1. Mycoplasma sp
2. Legoinella sp
3. Chlamydophilia sp |
|
|
Term
Beta-lactams
1. MOA
2. ADE (4)
3. Drug interaction (1) |
|
Definition
1. Bind PCN binding proteins causing cell lysis
2. Hypersensitivity rxns
GI disturbances (oral)
CNS toxicity (particularly renal dysfunction)
Nephrotoxicity
3. Probenacid |
|
|
Term
Penicillin VK
1. Brand
2. Route
3. Spectrum (3)
4. Category |
|
Definition
1. Veetids
2. PO
3. Streptococcus sp
Mouth Anaerobes
T. pallidum (syphillis, all stages)
4. Natrual PCN |
|
|
Term
Penicillin G Sodium
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Pfizerpen
2. IV/IM
3. 3. Streptococcus sp
Mouth Anaerobes
T. pallidum (syphillis, all stages)
4. Natural Penicillin |
|
|
Term
Penicillin G Procaine
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Wycillin
2. IM
3. 3. Streptococcus sp
Mouth Anaerobes
T. pallidum (syphillis, all stages)
4. Natural PCN |
|
|
Term
Penicillin G benzathine
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Bicillin-LA
2. IM
3. Streptococcus sp
Mouth Anaerobes
T. pallidum (syphillis, all stages)
4. Natrual PCN |
|
|
Term
Nafcillin
1. Brand
2. Route
3. Spectrum
4. Category
5. Renal dosing? |
|
Definition
1. Nafcil
2. IV
3. DOC for MSSA
4. Penicillinase-resistant PCN
5. No...biliary excretion so NO renal adjustment |
|
|
Term
Oxacillin
1. Brand
2. Route
3. Spectrum
4. Category
5. Renal dosing? |
|
Definition
1. Bactocil
2. IV
3. DOC MSSA
4. Penicillinase-resistant penicillins
5. No, biliary excretion |
|
|
Term
Dicloxacillin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Dynapen
2. PO
3. DOC for MSSA
4. Penicillinase=Resistant Penicillins |
|
|
Term
Amoxicillin
1. Brand
2. Spectrum |
|
Definition
1. Amoxil
2. Gm +: Streptocossu, enterococcus (DOC), listeria, anaerobes
GM -: E. coli, H. inflenzae, Proteus |
|
|
Term
Ampicillin
1. Brand
2. Spectrum
|
|
Definition
1. Principen
2. Gm +: Streptocossu, enterococcus (DOC), listeria, anaerobes
GM -: E. coli, H. inflenzae, Proteus |
|
|
Term
Piperacillin
1. Brand
2. Spectrum |
|
Definition
1. Pipracil
2. Gm +: Strep; Enterococcus
Gm -: Aminopenicllin spectrum (E. coli, H. inflenzae, Proteus) + Enterobacteriaceae, P. aeruginoa, Acinetobacter sp |
|
|
Term
Ticarcillin
1. Brand
2. Spectrum |
|
Definition
1. Ticar
2. Gm +: Strep; Enterococcus
Gm -: Aminopenicllin spectrum (E. coli, H. inflenzae, Proteus) + Enterobacteriaceae, P. aeruginoa, Acinetobacter sp |
|
|
Term
Beta-lactamases
Identify the generic of:
1. Augmentin
2. Unasyn
3. Zosyn
4. Timentin
5. Spectrum |
|
Definition
1. Amoxicillin/clavulanic acid
2. Ampicillin/sulbactam
3. Piperacillin/tazobactam
4. Ticarcillin/clavulanate
5. Increased gram - and anaerobic coverage
**Unasyn also covers Acinetobacter spp |
|
|
Term
Cephalosproins
1. Trend in spectrum from first to third gen
2. Cefepime spectrum
3 ADEs (3) |
|
Definition
1. Decreased gram + and increased Gm -/CNS penetration
2. Covers all three classes minus anaerobes
3. H/S (<1% cross-sensitivity)
GI effects
Pain at injection site (particularly IM) |
|
|
Term
Cefazolin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Ancef
2. IV/IM
3. GM +: Streptococcus and MSSA
4. 1st Gen Cephalosporin |
|
|
Term
Cephalexin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Keflex
2. PO
3. GM +: Streptococcus, MSSA
4. 1st Gen Cephalosporin |
|
|
Term
Cefadroxil
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Duricef
2. PO
3. GM +: Streptococcus, MSSA
4. 1st Gen Cephalosporin |
|
|
Term
Cefotetan
1. Brand
2. Route
3. Spectrum
4. Category
5. Special thing to remember |
|
Definition
1. Cefotan
2. IV
3. Increased GM - (E. coli, H flu, P. mirabilis)
4. 2nd Gen Cephalosporin
5. Tiomethyltetrazole (MTT) side chain that can cause bleeding/hyperprothrombinemia...disulfiram-like reactions may increase warfarin effects; Also has anaerobic activity |
|
|
Term
Cefoxitin
1. Brand
2. Route
3. Spectrum
4. Category
5. Specail thing about it |
|
Definition
1. Mefoxin
2. IV
3. Increased GM - (E. coli, H flu, P. mirabilis)
4. 2nd Gen Cephalosporin
5. Anaerobic activity |
|
|
Term
Cefprozil
1. Brand
2. Route
3. Spectrum
4. Category
5. What is special about it |
|
Definition
1. Cefzil
2. PO
3. Increased GM - (E. coli, H flu, P. mirabilis)
4. 2nd Gen Cephalosporin
5. Anaerobic Activity |
|
|
Term
Cefaclor
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Raniclor
2. PO
3. Increased GM - (E. coli, H flu, P. mirabilis)
4. 2nd Gen Cephalosporin |
|
|
Term
Cefuroxime
1. Brand (2)
2. Route
3. Spectrum
4. Category |
|
Definition
1. Ceftin; Zinacef
2. PO
3. Increased GM - (E. coli, H flu, P. mirabilis)
4. 2nd Gen Cephalosporin |
|
|
Term
2nd Generation Cephalosporins (brand/generic) and anything special about them (5) |
|
Definition
Cefotetan (Cefotan)*#
Cefoxitin (Mefoxin)*
Cefprozil (Cefzil)*
Cefaclor (Raniclor)
Cefuroxime (Ceftin, Zinacef) |
|
|
Term
1st gen cephalosporins (brand/generic)-3 |
|
Definition
1. Cefazolin (Ancef)
2. Cephalexin (Keflex)
3. Cefadroxil (Duricef) |
|
|
Term
Cefdinir
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Omnicef
2. PO
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin |
|
|
Term
Cefpodoxime
1. Brand
2. Route
3. Spectrum
4. Category
5. What is special |
|
Definition
1. Vantin
2. PO
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin
5. Anaerobic Activity |
|
|
Term
Cefixime
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Suprax
2. PO
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin |
|
|
Term
Cefditoren
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Spectracef
2. PO
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin
|
|
|
Term
Ceftibutin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Cedax
2. PO
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin |
|
|
Term
Ceftriaxone
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Rocephin
2. IV/IM
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin |
|
|
Term
Ceftazidime
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Fortaz
2. IV/IM
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin
**ANTI-pseudomonal |
|
|
Term
Cefotaxime
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Claforan
2. IV/IM
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin |
|
|
Term
Ceftizoxime
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Cefizox
2. IV
3. GM + (EXCEPT Ceftazidime)
GM-: Enterobacteriaceae (Ceftaz = P. aeruginosa)
4. 3rd Gen Cephalosporin |
|
|
Term
3rd Gen Cephalosporin Brand/Geneic (9) |
|
Definition
1. Cefdinir (Omnicef)
2. Cefpodoxime (Vantin)
3. Cefixime (Suprax)
4. Cefditoren (Spectracef)
5. Ceftibutin (Cedax)
6. Ceftriaxone (Recephin)
7. Ceftazidime (Fortaz)
8. Cefotaxime (Claforan)
9. Ceftizoxime (Cefizox) |
|
|
Term
Cefepime
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Maxipime
2. IV
3. GM + (Strep, MSSA)
Excellent GM -: P aeruginosa and Acinetobacter
**NO anaerobic activity
4. 4th Gen Cephalosporin |
|
|
Term
Ceftaroline
1. Brand
2. Route
3. Spectrum
4. Classification |
|
Definition
1. Teflaro
2. IV
3. GM+: MSSA, MRSA, Streptococcus
GM-: Limited: E. coli, Klebsiella, H. flu
4. Anti-MRSA Cephalosporin |
|
|
Term
Carbapenems
1. ADEs
2. DDIs |
|
Definition
1. H/S (1% cross-reactivity with PCNs)
Seizures (particularly with h/o seizure disorder or renal dysfunction)
2. Decreases valproic acid levels |
|
|
Term
Imipenem/cilastatin
1. Brand
2. Route
3. Spectrum
4. Classification |
|
Definition
1. Primaxin
2. IV
3. Very broad spectrum with most Gm +/- and anerobes covered
***DOES NOT cover P. aeruginosa or A. baumannii
4. Carbapenem |
|
|
Term
Meropenem
1. Brand
2. Route
3. Spectrum
4. Classificaiton |
|
Definition
1. Merrem
2. IV
3. Very broad spectrum with most Gm +/- and anerobes covered
***DOES NOT cover P. aeruginosa or A. baumannii
4. Carbapenem |
|
|
Term
Doripenem
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Doribax
2. IV
3. Very broad spectrum with most Gm +/- and anerobes covered
***DOES NOT cover P. aeruginosa or A. baumannii
4. Carbapenem |
|
|
Term
Ertapenem
1. Brand
2. Route
3. Spectrum
4. Classification |
|
Definition
1. Invanz
2. IV
3. Very broad spectrum with most Gm +/- and anerobes covered
***DOES NOT cover P. aeruginosa or A. baumannii
4. Carbapenem |
|
|
Term
Aztreonam
1. Brand
2. Route
3. Spectrum
4. ADEs
5. Category |
|
Definition
1. Azactam
2. IV
3. Gm - only : Including SPACE bugs except Acinetobacter
4. H/S...no reported Cross-reactivity with PCN
5. Monobactam |
|
|
Term
|
Definition
|
|
Term
Daptomycin
1. Brand
2. Route
3. Spectrum
4. Unique PK
5. ADEs
6. Category |
|
Definition
1. Cubicin
2. IV
3. Gm + (Including MRSA and VRE)
4. Inactivated by pulmonary surfactant...no tx for pneumonia
5. Musculoskeletal (CK weekly monitoring); GI effects; Peripheral effects (paresthesias and neuropathies)
6. Cyclic glycopeptide |
|
|
Term
Colistin, polymixin E
1. Brand
2. Spectrum
3. ADEs |
|
Definition
1. Coly-Mycin M
2. Gm - only: ONLY for MDR resistant organisms including P. aeruginosa and A. bacumannii
3. Nephrotoxicity; Neurotoxicity (NMB blockade; paresthesias around lips, tongue, extremeties; peripheral neuropathy) |
|
|
Term
Polymixin B
1. Brand
2. Spectrum
3. ADEs
|
|
Definition
1. Poly-Rx
2. Gm - only: ONLY for MDR resistant organisms including P. aeruginosa and A. bacumannii
3. Nephrotoxicity; Neurotoxicity (NMB blockade; paresthesias around lips, tongue, extremeties; peripheral neuropathy) |
|
|
Term
Ciprofloxacin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Cipro
2. IV, PO
3. GM -: Enterobacteriaceae; P. aeruginosa, atypicals
4. FQN |
|
|
Term
Levofloxacin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Levaquin
2. IV, PO
3. Gm +: Strep
Gm -: P. aeruginosa
Atypicals
4. FQN |
|
|
Term
Moxifloxacin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Avelox
2. IV, PO
3. Gm+: Strep
Gm -: Enterobacteriaceae (NO pseudomonas)
Atypical
Anaerobic (Moxi only)
4. FQN |
|
|
Term
Gemifloxacin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Factive
2. PO
3. Gm+: Strep
Gm -: Enterobacteriaceae (NO pseudomonas)
Atypical
4. FQN |
|
|
Term
Ofloxacin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Floxin
2. PO
3. Gm -: Enterobacteriaceae (NO pseudomonas)
Atypical
4. FQN |
|
|
Term
FQN
1. ADEs
2. Interactions |
|
Definition
1. GI
CNS (more common elderly)
Tendonitis/tendon rupture (BBW)
2. Absorption decreased with products containing Ca, Mg, Fe, Al, Zn
Use with steroids may increase tendon ruption
May potentiate warfarin |
|
|
Term
Metronidazole
1. Brand
2. Route
3. Spectrum |
|
Definition
1. Flagyl
2. IV/PO
3. Anaerobes only (good coverage of B. fragilis) |
|
|
Term
Metronidazole
1. MOA
2. ADEs
3. Interactions |
|
Definition
1. DNA helical structure disintegration
2. GI, CNS, Metallic taste, Potential carcinogen (BBW)
3. Possible disulfiram-like reaction
May inc effects of warfarin and lithium
Effects may be dec by phenobarb, phenytoin, and Inc by cimetidine |
|
|
Term
Rifampin
1. Brand
2. Route
3. MOA
4. Spectrum
5. Class |
|
Definition
1. Rifadin
2. PO
3. Inhibits B-subunity of DNA dep RNA pol
4. Wide spectrum, but common for: Staphy, mycobacterium, neisseria (meningitis propylaxis)
5. Rifamycin |
|
|
Term
Rifamycins
1. ADEs
2. Interactions |
|
Definition
1. GI
Discolored body fluids
Hematologic (thrombocytopenia, leukopenia, granulocytopenia)
2. Strong inducer of CYP 3A4, 1A2, 2C9, and 2C19 |
|
|
Term
Sulfamethoxazole-Trimethoprim
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Bactrim, Septra
2. IV/PO
3. Gm+: Staphy (including MRSA); Strep (not group A)
Gm-: Variable activity against (enterobacteriacae, DOC for stenotrophomonas maltophilia)
4. Folic Acid Inhibitors |
|
|
Term
Sulfamethoxazole-Trimethoprim
1. MOA
2. ADEs
3. Interactions |
|
Definition
1. Trimethoprim: DHFR
Sulfamethoxazole: DHPS
2. GI, Rash (relatively common causes of SJS or TEN)
3. Potent CYP 2C9 inhibitor
Potentiates warfarin, methotrexate, antidiabetic drugs
AVOID with G6PD deficiency |
|
|
Term
Protein inhibitors
1. 30 S (2)
2. 50S (4)
3. 30 and 50S |
|
Definition
1. Tetracyclines; Glycylcyclines
2. Macrolides; Lincosamides; Streptogrammins; Oxazolidinones
3. Aminoglycosides (ONLY CIDAL in this group) |
|
|
Term
Tetracycline
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. None given
2. PO
3. Gm +: staph (including MRSA) Strep (variable group A)
Gm-: Variable enterobacteriaceae
Anaerobes (not Bacteroides)
Atypicals
4. Tetracyclines |
|
|
Term
Doxycycline
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Vibramycin
2. IV/PO
3. Gm +: staph (including MRSA) Strep (variable group A)
Gm-: Variable enterobacteriaceae
Anaerobes (not Bacteroides)
Atypicals
4. Tetracyclines |
|
|
Term
Minocycline
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Minocin
2. IV/PO
3. Gm +: staph (including MRSA) Strep (variable group A)
Gm-: Variable enterobacteriaceae
Anaerobes (not Bacteroides)
Atypicals
4. Tetracyclines |
|
|
Term
Tetracyclines
1. ADEs (6)
2. Interactions |
|
Definition
1. H/S; Photosensitivity; Skin pigmentation changes; Discoloration of teeth/bones (children, CI in pregnant women and kids up to 8 yo); Vertigo (Minocin); GI (more with tetracycline)
2. Absorption decreased with Ca, Fe, Mg, Al, Zn; May dec effect of oral contraceptives; May increase effect of warfarin |
|
|
Term
Tigecycline
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Tygacil
2. IV
3. Broad;
Main hole in coverage: P. aeruginosa
4. Glycylcycline |
|
|
Term
Tigecycline
1. Unique PK
2. ADEs
3. Interactions |
|
Definition
1. Rapid distribution to periphery
**DO NOT use for bacteremia
2. GI (up to 30%)
Photosensitivity
3. May inc warfarin effects
May dec oral contraceptive effects |
|
|
Term
Erythromycin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Erythrocin
2. IV/PO
3. Gm+: Sterp; Listeria
Gm -: H flu; Moraxella
Atypicals
4. Macrolide |
|
|
Term
Azithromycin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Zithromax
2. IV/PO
3. Gm+: Sterp; Listeria
Gm -: H flu; Moraxella
Atypicals
4. Macrolide |
|
|
Term
Clarithromycin
1. Brand
2. Route
3. Spectrum
4. Category |
|
Definition
1. Biaxin
2. PO
3. Gm+: Sterp; Listeria
Gm -: H flu; Moraxella
Atypicals
4. Macrolide |
|
|
Term
Macrolides
1. ADEs
2. Interactions |
|
Definition
1. GI (particularly erythromycin)
H/S
2. Clarithromycin and erythromycin are major substrates and inhibitors of CYP3A4 and may prolong QT interval
All may increase effects of warfarin |
|
|
Term
Fidaxomicin
1. Brand
2. Route
3. Sepctrum
4. Category |
|
Definition
1. Dificid
2. PO
3. C. difficilie (cidal)
4. Classified as a macrolide |
|
|
Term
Fidaxomicin
1. MOA
2. Unique PK
3. ADEs |
|
Definition
1. Inhibits RNA synthesis via RNA polymerase inhibition
2. Minimal systemic absorption
3. GI effects
Anemia/Neutropenia |
|
|
Term
Clindamycin
1. Brand
2. Route
3. Spectrum
4. Category
5. ADEs |
|
Definition
1. Cleocin
2. IV/PO
3. Gm +: Strep, Staph (including MRSA)
Anaerobes (not reliable against B. fragilis)
4. Lincosamide
5. GI/Pseudomembranous colitis (BBW) |
|
|
Term
Quinupristin-dalfopristin
1. Brand
2. Spectrum
3. Category
4. ADEs
5. Interactions
|
|
Definition
1. Synercid
2. Gm + only
3. Streptogrammin
4. GI; Arthralgia/myalgia; Hyperbilirubinemia
5. Potent CYP3A4 inhibitor |
|
|
Term
Linezolid
1. Brand
2. Spectrum
3. Category
4. ADEs
5. Interactions |
|
Definition
1. Zyvox
2. Gm + only including MRSA and VRE
3. Oxazolidinone
4. GI; Myelosuppression (esp if >2 wk duration); Neuropathies (peripheral and optic)
5. 5-HT syndrome wiht SSRI use; Reversible non-selective MAOIs alays cause 5-HT syndrome |
|
|
Term
NItrofurantoin
1. Brand
2. Spectrum
3. MOA
4. ADE |
|
Definition
1. Macrobid, Macrodantin
2. Gm +
Gm -: some enterobacteriaceae (E. coli and Citrobacter)
3. Reduced by flavoproteins to active intermediates that damage robisomal proteins, DNA, and RNA (only active in urine so not effective if CrCl<60 mL/min)
4. GI; Pulmonary reactions |
|
|
Term
Define
1. Antimicrobial resistance
2. MDR Pathogens |
|
Definition
1. The abiliyt of microbes to grow in the presence of a chemical (drug) that would normally kill or limit its growth
2. Resistant to 3+ drugs commonly used to treat the bug |
|
|
Term
|
Definition
1. Enzymes destroy ABX
2. Mutation at binding site
3. Downregulation of membrane proteins allowing access to inside
4. Efflux pump that removes ABX from cell |
|
|
Term
Define resistance mechanisms for
1. B-lactams
2. AGs
3. FQNs
4. Macrolides
5. Tetracyclines
6. Vanc |
|
Definition
1. Target alteration, dec perm, enzyme degradation
2. Reduced perm, enzyme degredation
3. Efflux; target alteration; reduced perm
4. Efflux; target alteration
5. Efflux
6. Alteration of target |
|
|
Term
|
Definition
Enterococcus faecium
Staphylococcus aureus
Klebsiella pneumonia
Acinetobacter baumannii
Pseudomonas aeruginosa
Enterobacter sp |
|
|
Term
|
Definition
1. Vanc
2. Dapto
3. Linezolid
4. Telavancin
5. Ceftaroline
6. Clinda
7. Tetracyclines (including tigecyl)
8. Synercid
9. Bactrim |
|
|
Term
|
Definition
1. Ampicillin
2. Linezolid
3. Dapto
4. Nitrofurantoin
5. Tetracyclines |
|
|
Term
Extended Spectrum B-lactamase Gm -
1. Resistant to what
2. Most common with
3. TOC |
|
Definition
1. 1st, 2nd, 3rd gen cephalosporins (not cefoxitin or cefotetan) and monobactams
2. K. pneumoniae and E. coli
3. Carbapenems |
|
|
Term
AmpC B-lactamases Gm -
1. Resistant to
2. Typically occurs in |
|
Definition
1. All B-lactams except carbapenems
2. Enterobacter, Citrobacter, M. morganii, Serratia, P. aeruginosa |
|
|
Term
Klebsiella pneumoniae carbapenemase (KPC) Gm-
1. Resistant to
2. Occurs in
3. TOC |
|
Definition
1. All B-lactams INCLUDING carbapenems
2. K. pneumoniae, E. coli, Citrobacter, Enterobacter, Serratia, P. aeruginosa
3. AG + Polymixin |
|
|